Felipe Couñago

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Felipe Couñago

Jan 6, 2025, 14:37 | Science

Felipe Couñago: Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients

Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a recent article on X: "Our…

Oct 20, 2024, 12:48 | Insight

Reza Ghalehtaki: TNT is the new standard of care for LARC

Reza Ghalehtaki, Radiation Oncologist at Cancer Institue of Iran, shared a post on X: "Hot…

Aug 27, 2024, 03:11 | Insight

Castalia Fernández: The molecular era of treatment of gliomas

Castalia Fernández, Radiooncologist at GenesisCare Spain, shared a post on X: “Editorial! Current challenges in…

Aug 14, 2024, 02:11 | Insight

Felipe Couñago: Analyzing diagnostic and treatment wait times for lung cancer Patients

Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X about a…

Jun 9, 2024, 15:06 | Blog

Felipe Couñago: Our study on ADC as an early prognostic marker has been accepted in ASTRO

Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X: "Our study…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023